BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KESHO
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260409T190000
DTEND;TZID=Africa/Nairobi:20260509T203000
DTSTAMP:20260527T190327
CREATED:20260526T192731Z
LAST-MODIFIED:20260526T193025Z
UID:41708-1775761200-1778358600@kesho-kenya.org
SUMMARY:The Role of Multimodal Treatment in Esophageal Cancer
DESCRIPTION:Moderator: Dr. Omar Abdihamid\nSpeakers: Dr. Juma Odoro\, Dr. Rogers Mongare\, Dr. Kevin Makori\nDate: 9 April 2026\n\nThis session examined esophageal cancer management through a multidisciplinary lens\, bringing together surgical\, radiotherapeutic and systemic treatment perspectives across the continuum of care. \nA central theme was that treatment selection depends on accurate staging\, patient fitness\, disease burden and early alignment between disciplines. In many African settings\, patients may present with locally advanced disease and nutritional compromise\, making timely diagnosis\, staging and supportive care central to outcomes. \nThe surgical discussion focused on the role of resection in appropriately selected patients\, where careful assessment of resectability\, operative risk\, nodal disease and perioperative optimisation shape whether surgery can offer curative benefit. The session also reinforced that surgery is rarely a standalone decision; it must be integrated with oncology input and long-term follow-up. \nRadiotherapy was addressed as part of multimodal care\, with roles in neoadjuvant\, definitive\, adjuvant and palliative pathways depending on stage and patient factors. The discussion highlighted the need for precise planning\, symptom control and realistic treatment pathways that reflect available infrastructure and patient access. \nIn metastatic disease\, systemic therapy remains central\, with evolving use of combination approaches\, targeted treatment and biomarker-directed strategies. However\, implementation must be balanced with access\, cost\, toxicity\, performance status and local service realities. \nAcross the session\, a consistent message emerged: esophageal cancer care requires deliberate sequencing—matching the right treatment to the right patient at the right point in the disease course. \nKey Takeaways\n\nEsophageal cancer management depends on accurate staging\, nutrition assessment and multidisciplinary planning.\nSurgery remains important in resectable disease but requires careful patient selection and perioperative optimisation.\nRadiotherapy has curative\, consolidative and palliative roles within multimodal treatment.\nMetastatic disease management is evolving with systemic combinations and biomarker-driven options.\nAccess\, treatment tolerance and supportive care shape real-world implementation in Kenya and the wider region.\nEarly referral and MDT decision-making are critical to improving outcomes.
URL:https://kesho-kenya.org/event/the-role-of-multimodal-treatment-in-esophageal-cancer/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2026/05/The-Role-of-Multimodal-Treatment-in-Esophageal-Cancer-e1779823765248.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260416T190000
DTEND;TZID=Africa/Nairobi:20260416T203000
DTSTAMP:20260527T190327
CREATED:20260526T192507Z
LAST-MODIFIED:20260526T193940Z
UID:41705-1776366000-1776371400@kesho-kenya.org
SUMMARY:Bridging Surgery and Oncology in Head & Neck Cancer
DESCRIPTION:Moderator: Dr. Ahmed Komen\nSpeakers: Dr. Anthony Kenyanya\, Dr. Anthony Ndiritu\nDate: 16 April 2026\n\nThis session explored the management of head and neck cancer with particular attention to how surgical decisions and oncology pathways must align from the outset. Through oral cavity cancer as a key focus\, the session examined resectability\, margins\, nodal management\, reconstruction\, adjuvant therapy and functional outcomes. \nA central theme was that treatment planning must go beyond tumour removal. Dr. Anthony Kenyanya highlighted the importance of staging\, imaging\, pathology\, dental and nutritional assessment\, surgical access\, margin planning and neck node evaluation. In oral cavity cancers\, surgical success depends not only on clear oncologic resection\, but also on the ability to reconstruct defects and preserve speech\, swallowing\, appearance and quality of life. \nThe discussion also emphasised the challenge of late presentation and complex anatomy. Selective neck dissection\, sentinel node considerations\, access procedures such as mandibulotomy\, and the reconstructive ladder were framed as tools for balancing disease control with morbidity. The role of the pathologist and margin assessment was highlighted as central to determining risk and guiding further treatment. \nDr. Anthony Ndiritu built on this by outlining how radiotherapy and chemoradiation fit into early\, locally advanced\, post-operative\, recurrent and metastatic diseases. Early-stage disease may often be treated with a single modality\, while locally advanced disease requires careful integration of surgery\, radiotherapy and chemotherapy. \nPositive margins and extranodal extension were discussed as major indications for post-operative chemoradiation\, with timely initiation of treatment after surgery being important. The session also addressed treatment technique\, patient fitness\, nutrition\, supportive care and the need to tailor recommendations to the services and expertise available. \nAcross the session\, a consistent message emerged: head and neck cancer care is as much about function\, coordination and follow-through as it is about disease control. \nKey Takeaways\n\nHead and neck cancer decisions must integrate tumour stage\, resectability\, patient fitness and functional outcomes.\nMargin planning\, pathology reporting and neck node assessment directly shape adjuvant treatment decisions.\nSurgery requires strong reconstruction and rehabilitation planning to preserve speech\, swallowing and appearance.\nLocally advanced disease often needs combined-modality treatment through an MDT approach.\nPositive margins and extranodal extension are key triggers for post-operative chemoradiation.\nSupportive care\, nutrition and patient navigation are essential to treatment completion.
URL:https://kesho-kenya.org/event/bridging-surgery-and-oncology-in-head-neck-cancer/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2026/05/Bridging-Surgery-and-Oncology-in-Head-Neck-Cancer-e1779824360609.png
END:VEVENT
END:VCALENDAR